Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine-Reference-Cited by-同舟云学术

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

Published:2021-10-29 Issue:44 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

McMillan Christopher L. D.¹^ORCID,Choo Jovin J. Y.¹^ORCID,Idris Adi²^ORCID,Supramaniam Aroon²,Modhiran Naphak¹^ORCID,Amarilla Alberto A.¹,Isaacs Ariel¹^ORCID,Cheung Stacey T. M.¹^ORCID,Liang Benjamin¹^ORCID,Bielefeldt-Ohmann Helle¹³⁴,Azuar Armira¹^ORCID,Acharya Dhruba²,Kelly Gabrielle²^ORCID,Fernando Germain J. P.¹⁵^ORCID,Landsberg Michael J.¹³^ORCID,Khromykh Alexander A.¹³,Watterson Daniel¹³^ORCID,Young Paul R.¹³^ORCID,McMillan Nigel A. J.²^ORCID,Muller David A.¹^ORCID

Affiliation:

1. School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland 4072, Australia.

2. Menzies Health Institute Queensland, School of Pharmacy, Anatomy and Medical Sciences, Griffith University, Gold Coast, Queensland 4222, Australia.

3. Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, Queensland 4072 and 4029, Australia.

4. School of Veterinary Science, University of Queensland Gatton Campus, Gatton, Queensland 4343, Australia.

5. Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Brisbane, Queensland 4102, Australia.

Abstract

Delivery of a SARS-CoV-2 vaccine to the skin of mice via microarray patches provides complete protection from challenge.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference71 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

3. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

4. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

5. Immunogenicity of a DNA vaccine candidate for COVID-19

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein;Journal of General Virology;2024-01-25

2. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity;mBio;2024-01-09

3. Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine;Molecular Therapy - Nucleic Acids;2023-12

4. Microarray patches: scratching the surface of vaccine delivery;Expert Review of Vaccines;2023-10-27

5. Fourth dose of Microneedle Array Patch of SARS-CoV-2 S1 Protein Subunit Vaccine Elicits Robust Long-lasting Humoral Responses in mice;2023-10-05